Perceptive Advisors - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 56 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,379,000
+65.1%
294,1180.0%0.07%
+53.3%
Q2 2022$1,441,000
-79.3%
294,1180.0%0.04%
-67.6%
Q1 2022$6,956,000
-33.2%
294,118
-50.0%
0.14%
+73.8%
Q4 2021$10,406,000
+25.4%
588,236
+100.0%
0.08%
-33.9%
Q3 2021$8,297,000
+34.6%
294,118
-50.0%
0.12%
+202.5%
Q2 2021$6,164,000
-60.9%
588,236
-34.2%
0.04%
-84.4%
Q2 2020$15,768,000
+120.1%
894,118
+49.0%
0.26%
+36.9%
Q1 2020$7,164,000
-28.2%
600,0000.0%0.19%
-5.6%
Q4 2019$9,984,000
+150.6%
600,0000.0%0.20%
+85.0%
Q3 2019$3,984,000600,0000.11%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders